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Abstract
The biological activities of NGF and of its precursor proNGF are quite distinct, due to different receptor binding profiles, but
little is known about how proNGF regulates gene expression. Whether proNGF is a purely pro-apoptotic molecule and/or
simply a ‘‘less potent NGF’’ is still a matter of debate. We performed experiments to address this question, by verifying
whether a proNGF specific transcriptional signature, distinct from that of NGF, could be identified. To this aim, we studied
gene expression regulation by proNGF and NGF in PC12 cells incubated for 1 and 4 hours with recombinant NGF and
proNGF, in its wild-type or in a furin-cleavage resistant form. mRNA expression profiles were analyzed by whole genome
microarrays at early time points, in order to identify specific profiles of NGF and proNGF. Clear differences between the
mRNA profiles modulated by the three neurotrophin forms were identified. NGF and proNGF modulate remarkably distinct
mRNA expression patterns, with the gene expression profile regulated by NGF being significantly more complex than that
by proNGF, both in terms of the total number of differentially expressed mRNAs and of the gene families involved.
Moreover, while the total number of genes modulated by NGF increases dramatically with time, that by proNGFs is
unchanged or reduced. We identified a subset of regulated genes that could be ascribed to a ‘‘pure proNGF’’ signalling,
distinct from the ‘‘pure NGF’’ one. We also conclude that the composition of mixed NGF and proNGF samples, when the two
proteins coexist, influences the profile of gene expression. Based on this comparison of the gene expression profiles
regulated by NGF and its proNGF precursor, we conclude that the two proteins activate largely distinct transcriptional
programs and that the ratio of NGF to proNGF in vivo can profoundly influence the pattern of regulated mRNAs.
Citation: D’Onofrio M, Paoletti F, Arisi I, Brandi R, Malerba F, et al. (2011) NGF and proNGF Regulate Functionally Distinct mRNAs in PC12 Cells: An Early Gene
Expression Profiling. PLoS ONE 6(6): e20839. doi:10.1371/journal.pone.0020839
Editor: Alfred Lewin, University of Florida, United States of America
Received January 18, 2011; Accepted May 12, 2011; Published June 3, 2011
Copyright:  2011 D’Onofrio et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The work was funded by grant PNR RBIP063ANC from the Italian Ministry of Higher Education and Scientific Research and IIT Grant from the Italian
Institute of Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: antonino.cattaneo@sns.it
. These authors contributed equally to this work.
Introduction
NGF (Nerve Growth Factor), the prototype member of the
neurotrophin protein family [1], is involved in the maintenance
and growth of specific neuronal populations, both in the central
and peripheral nervous system, through the interaction with two
receptors: TrkA, a member of the Tyrosine Kinase receptors
superfamily [2], and p75
NTR, belonging to the Tumor Necrosis
Factor (TNF) receptor superfamily [3].
As all neurotrophins, NGF is translated as a pre-pro-protein [4].
In the case of NGF, two alternative translation initiation sites have
been identified, leading to the formation of two precursor proteins,
a long and a short form, respectively (Figure 1A), that are
glycosylated in vivo [5]. The signal peptide is cleaved upon
translocation into the endoplasmic reticulum, and the protein is
further processed by furin protease in the trans-Golgi network
[6,7] or by extracellular proteases [8,9], to give rise to mature
NGF.
Besides its suggested roles as a precursor to mature NGF in the
regulation of neurotrophin secretion [10] and as an intramolecular
chaperone [11,12], proNGF was found to display independent
biological activities, different from those of its mature NGF
counterpart, mediated by distinct, and somewhat complementary,
receptor binding properties [13,14]. In transfected cells and
cultured neurons, proNGF was shown to induce p75
NTR-
dependent apoptosis [8,15,16], but also TrkA dependent neuronal
survival, although less effectively than mature NGF [17]. proNGF
is the predominant form of NGF in normal brain and its levels
increase in the brain of patients affected by Alzheimer’s Disease
(AD) [18].
Sortilin, a member of the family of Vps10p-domain receptors,
was identified as a specific receptor for proNGF [13] and proposed
to control the sorting pathways of pro-neurotrophins [19–21]. The
activation of the death signal by proNGF requires its interaction
with both sortilin and p75
NTR receptors [13,22–24]. The protein
levels of proNGF, TrkA, p75
NTR and sortilin appear to be
differently modulated in AD brains [25,26].
The overall picture of neurotrophins activity, as precursors or as
mature proteins, is therefore more complicated than previously
thought. Whether proNGF is a true apoptotic molecule or a sort of
‘‘less potent NGF’’ is still a matter of debate [8,17] and different
biological outcomes of NGF and proNGF signalling have been
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[27,28], on the presence of different kinds of proteases [9,21,29]
and on the expression levels of the receptors [30].
It is therefore crucial to address the question of whether, and to
what extent, NGF and proNGF have distinct signalling properties,
and whether the reported differences in their activities are
qualitative (i.e. highly distinct), or purely quantitative.
To this aim, in this paper we have undertaken a gene expression
profiling study, aimed at analyzing to what extent proNGF and
NGF activate different transcriptional programs in the NGF
responsive cell line PC12, which expresses the full complement of
NGF and proNGF receptors. PC12 cells were cultured for short
times with equimolar amounts of recombinant mouse NGF
(hereon simply called NGF) or two forms of recombinant mouse
Figure 1. Description of proNGF and its stability. Panel A: Schematic representation of the short form of proNGF. The arrows mark the cleavage
sites for furin, the double headed arrows represent the C-terminal processing site (post translational modification) and hexagons the potential N-
glycosylation sites. In red, the di-basic amino acids that are important in the processing of the protein. In green, the consensus site for the cleavage
by furin. In the present study, we obtained furin resistant mutants in this site (mutant proNGF-KR: RSKR to RSAA [52]). Panel B: Western blot to test the
stability of the proNGF samples in PC12 cells. PC12 cells were plated and treated for 1 h or 4 h with 20 ng/mL of proNGF-WT or proNGF- KR or 10 ng/
mL of NGF. Then, the medium was taken and 1 mg of recombinant proNGF or proNGF-KR or NGF was spiked into 50 mL of conditioned medium.
Spiking controls in fresh medium and PBS were also carried out. The spiked medium was incubated at 37uC for 1 h or 4 h. The red arrow marks the
band corresponding to the full length proNGF, the blue arrow marks the band corresponding to mature NGF. In the figure, WT stands for proNGF-WT
and KR stands for proNGF-KR. Panel C: Densitometric analysis performed on the Western Blot of the spiking experiments representing the percentage of
proNGF proteolysis. The bands corresponding to proNGF and NGF in the Western blot challenged with the anti-NGF antibody were quantified. The
resulting intensities, normalized against the areas of the bands, were reported in the histogram. For each lane, corresponding to the different
proNGF-WT or -KR treatments, the band intensities of proNGF and NGF, derived from proNGF proteolysis, were measured and the sum of the two
bands intensities was assigned to a value of 100%. Among this total intensity, the intensity of the bands corresponding to proNGF and mature NGF
was evaluated and expressed as %. The histogram is the result of the average of four independent experiments.
doi:10.1371/journal.pone.0020839.g001
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called proNGF-WT or proNGF-KR). The gene expression
changes in response to the different treatments were investigated
by microarray analysis.
The results show unequivocally that, at this relatively short time
scale, NGF and proNGF regulate the expression of significantly
different sets of mRNAs.
Results
1. proNGF- versus NGF-regulated gene expression in
PC12 cells: experimental design and validation studies
The experiment was designed to verify to what extent NGF and
proNGF activate different signalling pathways, thereby regulating
distinct sets of mRNAs, in the NGF responsive PC12 cells, an
extensively used model to study NGF-induced differentiation [31].
These cells express the full complement of NGF and proNGF
receptors (TrkA, p75NTR [32] and sortilin - Figure S1). The
initial signalling cascades triggered by NGF stimulation and the
patterns of NGF regulated mRNAs have been well characterized
in PC12 cells. On the other hand, nothing is known, so far, about
how proNGF influences gene expression, in this or in other
cellular systems.
The bioactivity of the recombinant NGF and proNGF proteins
was verified by incubating naı ¨ve PC12 cells with equimolar
amounts of NGF and the short form of proNGF, both in its wild-
type (proNGF-WT) and in its furin-resistant form (proNGF-KR).
The proNGF-WT and proNGF-KR proteins (Figure 1A) were
expressed in E.coli and purified, as described in the Methods
Section. The mature NGF was derived from proNGF-WT by
controlled trypsin proteolysis in vitro [14].
We first verified through a standard PC12 cells bioassay (50 ng/
mL of NGF and 100 ng/mL of the short form of proNGF, both
WT and KR) that the recombinant proteins used for the
experiments are able to induce an equivalent extent of
morphological differentiation after 72 hours exposure (Figure
S2), and are therefore active, in the frame of our experiment.
PC12 cells treated with proNGF -WT and –KR had a normal
morphology and not apparent sign of apoptotic cells was observed.
Indeed, it has been reported that after long time exposure, both
NGF and proNGF induce neurite sprouting in PC12 cells [14,33].
The final goal of the present work was to specifically evaluate
cellular responses to NGF and proNGF separately, in terms of
early transcriptional expression profiles. Therefore, we focussed on
a short-term exposure of naı ¨ve PC12 cells to NGF or proNGF (1 h
and 4 h). Sub-saturating concentrations of the proteins were used
(namely 10 ng/mL for NGF and 20 ng/mL for the short form of
proNGF, both WT and KR), in order to isolate the specific early
cellular responses.
We assessed the morphology of the PC12 cells in response to the
NGF and proNGF 1 h and 4 h treatments. A macroscopic
evaluation of the cells upon treatment with the neurotrophins
(Figure 2) does not show any significant difference at the early time
points used for the microarray study. Specifically, we cannot
identify any difference at 1 h, while at 4 h NGF-treated cultures
start showing a frequent incipient differentiated morphology,
which only in rare cells is observed in both proNGF treated
cultures.
The ability of this PC12 cells clone to undergo apoptosis upon
treatment with proNGF was tested. In particular, cells were
treated with the described amounts of neurotrophins (namely
10 ng/mL for NGF and 20 ng/mL for proNGF, both WT and
KR) and apoptosis was evaluated at both 1 h and 4 h by means of
TUNEL method (Terminal deoxynucleotidyl transferase dUTP
nick end labeling) using the ApopTag detection Kit. We could not
find any significant difference in the percentage of apoptosis
induced by either proNGF-WT or –KR, when compared to the
NGF treatment or the control (data not shown).
The stability of the recombinant proNGF proteins, over the
same time scale of the microarray experiment, was assessed in the
culture conditions of the neurotrophin treatment of PC12 cells, in
order to compare the extent of processing of the wild-type and
furin-resistant proNGF proteins.
A known (and measurable) amount of NGF, proNGF-WT and -
KR was spiked into PC12 conditioned medium and incubated in
the same conditions of temperature and time used for the cells’
treatment (see Materials and Methods). The extent of proNGF
degradation (the ratio between intact proNGF and the NGF
produced by proNGF processing) was evaluated by Western blot
analysis (Figure 1B) and densitometric analysis of the bands
corresponding to those of proNGF and NGF originating from the
proNGF proteolysis (Figure 1C).
As shown in Figure 1B and 1C, the proNGF samples are not
cleaved upon incubation in PBS buffer, nor in fresh culture medium
upon the longer incubation (4 h). As expected, incubation of
proNGF samples for 1 h and 4 h in the corresponding PC12
conditioned medium yields to their partial degradation (Figure 1B).
There are no substantial differences in the amount of NGF released
from both proteins, at the two time points, as seen in Figure 1C.
Therefore, we conclude that while the KR mutation does not
completely impair proNGF processing, due to extracellular
proteases, besides intracellular furin, present in the PC12
conditioned medium [8,9], the cleavage of proNGF-KR could
be different than that of wild-type proNGF. Indeed, the kinetic of
processing of the WT and the KR mutant are not easily
measurable. Therefore, we cannot exclude that there might be
different cleavage kinetics of the two proteins in vivo. The kinetics
would account for a difference in the NGF/proNGF ratio in the
system in the two cases, during the proteolysis progression, at
different time points.
The transcriptional profile regulated by NGF was analyzed first,
in order to set a comparison with published data [34–48],
confirming the well established activation of immediate early gene
after NGF treatment of PC12 cells [37,47,49,50]. Figure 3 reports
the analysis for immediate early genes and for other genes known
to be induced early by NGF. Many of these genes encode possible
transcription factors, and thus may play roles in the initiation and
regulation of subsequent responses to NGF (for review, [38]).
It is noteworthy that none of these immediate early genes is
activated to any significant extent by either proNGF-WT or
proNGF-KR (Figure 3), suggesting already from the analysis of
this first set of genes that NGF and proNGF may activate distinct
transcriptional programs.
2. Distinct mRNA expression patterns are regulated by
NGF and proNGF
The differential activation of immediate early genes by NGF
versus proNGF (Figure 3) suggests that their transcriptional
responses may be significantly different. Therefore, the overall
statistics of the whole dataset of differentially expressed genes were
evaluated. This analysis showed that NGF and proNGF regulate
distinct mRNA sets in PC12 cells (Table S1), over the time scale
investigated.
Figure 4A illustrates the overall counts of the differential genes.
Among the different intersection areas of the Venn diagram, we
focussed our analysis on the coloured regions shown in Figure 4B,
highlighting the specific proNGF fingerprinting compared to the
NGF one. Genes activated exclusively by NGF are found in the
Transcriptional Signature of proNGF in PC12 Cells
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are represented in orange and blue, respectively; the brown region
represents the overlap of the genes activated by proNGF WT and
KR, but not by NGF. We refer to the brown region as the ‘‘pure
proNGF’’ activated genes set. The ‘‘pure proNGF’’ set identifies,
therefore, the genes most likely to be affected exclusively by the
proNGF component of the neurotrophin mixture, and provides
therefore a fingerprint of proNGF activity on a given cell. It is
interesting to notice that in this ‘‘pure proNGF’’ intersection set,
all the genes have the same trend in both the proNGF-WT and -
KR preparation, that is either both up-regulated or both down-
regulated (Table S1).
At 1 h, the total number of mRNAs exclusively regulated by
NGF (N=436, ‘‘pure NGF’’ cyan colour in Figure 4B) is very
similar to the total number of mRNAs regulated by proNGF-WT
(N=444 orange colour in Figure 4B), while proNGF-KR regulates
a lower number of mRNAs (N=204, blue colour in Figure 4B).
The picture changes completely at 4 hours, when the total number
of differentially expressed genes is very different for the proNGF or
NGF treated cultures, showing that the number of genes up- or
down-regulated by proNGF-WT (N=178, colour orange in
Figure 4B) or the pro-NGF-KR (N=224, colour blue in
Figure 4B) is about ten times lower than the number of mRNAs
differentially regulated by NGF (N=2231, colour cyan in
Figure 2. PC12 cells treated for 1 h or 4 h with equimolar amounts of the recombinant neurotrophins. Phase contrast pictures (upper
two rows, 206magnification) of PC12 cells in culture and confocal images of triple immunofluorescence of PC12 cells (last four rows) respectively for
betaIII-tubulin (green), actin (red) and DNA (blue) (636magnification) and immunofluorescence for actin cytoskeleton (1006magnification). After 1 h
or 4 h cells were fixed and stained with anti-betaIII tubulin antibody, Alexa 594 phalloidin to visualize filamentous actin and DAPI for nuclear staining.
- first column: control cells with no addition. - second column: 10 ng/mL of NGF. - third column: 20 ng/mL of proNGF WT. - fourth column: 20 ng/mL
of proNGF KR.
doi:10.1371/journal.pone.0020839.g002
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proNGF’’ genes is unchanged at 1 and 4 hours.
In the case of NGF treated cells, the increase in the amount of
differential genes from 1 h to 4 h time is a result of the well known
early activation of transcription factors following NGF exposure.
proNGF does not share this property of NGF, showing a more
restricted response at 4 hours.
The differential regulation of gene expression in PC12 by NGF
and proNGF was further analyzed by comparing the correspond-
ing distributions of relative frequencies of ‘‘fold variation’’ ratio
(NGF or proNGF treated PC12/naı ¨ve PC12) for differentially
expressed mRNAs (Figure 5). As shown in the Figure 5, the overall
cumulative distribution for NGF regulated genes is shifted towards
higher fold variation values than the overall distribution for
proNGF-WT and proNGF-KR regulated genes. The fold change
values at 90% of the cumulative distribution at 1 h for NGF,
proNGF-WT and proNGF-KR are respectively 1.40, 1.32 and
1.30, while at 4 h they are 1.74, 1.29 and 1.32 respectively. The
fold change distributions were compared using the 2-tails
Kolmogorov-Smirnov test for two samples and were found to be
significantly different. Thus, NGF exerts a much more potent and
widespread regulation of mRNA expression than proNGF, both in
terms of number of regulated genes and of fold variation.
3. Functional analysis of NGF and proNGF regulated
genes
The microarray datasets were functionally analyzed by
bioinformatics tools, to learn more about the nature of
differentially expressed genes and about specific mechanisms or
pathways significantly modulated in the different experimental
groups. To this aim, differentially expressed genes for each
treatment and time point were grouped into functional
categories. To this aim, 208 differentially expressed genes for
each treatment and time point were grouped into 209 functional
categories, by the Panther Ontology tool. As a first step, using the
Panther onthology tool, 8 disjoint lists of statistically significant
Panther Biological Processes were obtained (Table S2), one for
each treatment (NGF, proNGF-WT, proNGF-KR and the
intersection) and time point (1 and 4 hours), using the whole
filtered normalized transcriptomic dataset (see Materials and
Methods). Starting from these Panther categories, a more detailed
functional analysis was performed, by investigating, out of the
whole normalized dataset, only the differentially expressed genes.
Therefore, as a second step, 8 sets of differentially expressed
genes were compiled, showing fold-change values larger than 1.2
or lower than 1/1.2 in the linear scale (see Materials and
Methods): these genes were further filtered by selecting those
belonging to statistically significant Panther Biological Processes,
and eventually classified into the categories summarized in
Table 1.
Among all the functional categories listed in Table 1, the
following ones were analyzed in details: the transcription factor
family, well represented only in the NGF treatment dataset, the
lipid metabolism one, specific for the ‘‘pure proNGF’’ set, and the
cell cycle and DNA repair families, that are common between
NGF and proNGF specific sets.
Figure 3. Relative expression data of typical early NGF-responsive genes, 1 hour after NGF, proNGF-WT, proNGF-KR treatments.
The gene symbols refer to the following gene names: Egr1 (also known as Tis8)=early growth response 1; Egr2=early growth response 2;
Egr4=early growth response 4; Btg2 (also known as Pc3)=B-cell translocation gene 2, anti-proliferative; Fos=FBJ murine osteosarcoma viral
oncogene homolog; Ier2=immediate early response 2; Nr4a1 (also known as Tis1)=nuclear receptor subfamily 4, group A, member 1; Jun=Jun
oncogene; Atf3=activating transcription factor 3; Junb=Jun-B oncogene; Arc=activity-regulated cytoskeleton-associated protein; Fosl1=fos-like
antigen 1; Klf4=Kruppel-like factor 4 (gut); Ier3=immediate early response 3; Cited2=Cbp/p300-interacting transactivator, with Glu/Asp-rich
carboxy-terminal domain, 2; Id1=Inhibitor of DNA binding 1, helix-loop-helix protein (splice variation); zfp36 (also known as Tis11)=zinc finger
protein 36; Ifrd1 (also known as Pc4)=interferon-related developmental regulator 1; Id3=inhibitor of DNA binding 3; Vgf=VGF nerve growth factor
inducible.
doi:10.1371/journal.pone.0020839.g003
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theproNGFtreatments.Analyzingindetailthegenesincludedinthis
category for the NGF specific set and the proNGFs intersection set,
after 1 h treatment, two distinct trends can be highlighted (Figure 6).
Weobserve indeedthat,after1 h treatment,while NGFactivatesthe
expression of a mitotic and anti-apoptotic outcome mRNAs,
proNGFsactivatespro-apoptoticgenes,including tumoursuppressor
mRNAs. It is noteworthy that the ‘‘proliferative signature’’ is
conserved for NGF, also at 4 hours of treatment, while the
proapoptotic signature is not maintained for proNGFs transcrip-
tional response at 4 hours. This could be due to a contribution of the
fraction ofmatureNGFderived from the cleavage oftheprecursor,a
contribution that increases with incubation time.
The differential regulation of genes coding for transcription
factors represents another major distinction signature of NGF
versus proNGF in PC12 cells. A summary count of the
transcription factors differentially expressed in this system by
NGF and proNGF is reported in Table 2, that shows a reduced
number of transcription factor genes represented in the proNGF
intersection set, compared to the NGF treatment set at 1 hour.
The number of the differentially expressed transcription factor
genes in the ‘‘pure proNGF’’ or NGF treated cells is strikingly
different at 4 h, being much lower in the proNGF group, pointing
out a specific fingerprinting of the proNGF.
Table 3 describes the analysis of the main functional categories
of genes whose expression levels correlate with those of the
transcription factors modulated by the NGF or proNGF. This kind
of analysis reconstructs a snapshot of the general status of the cell.
ProNGF signalling indicates an early involvement of mitochon-
drial and metabolic genes, while NGF confirms the induction of
the transcription response, gene expression and angiogenesis
related genes. The picture of the cell treated with NGF is
characterised by an increased metabolism of the cell preparing
itself to progress toward the cell cycle division, while proNGF
treated cell could be less active.
Other differences between NGF and proNGF signalling reside
in DNA replication and chromatin remodelling gene families,
where several genes involved in DNA repair are differentially
expressed after exposure to either NGF or proNGF (-WT or -KR),
but in opposite directions. NGF at 4 h mainly down-regulates
DNA repair genes, such as DNA polymerase subtype, primarily
involved in repair and other related enzymes. Instead, 1 h of
treatment with proNGF (either -WT or -KR) up-regulates DNA
repair genes, both specific DNA polymerase involved in repair
Figure 4. Overall statistics of differentially expressed genes. We selected genes with a fold change larger than 1.2 or lower than 1/1.2 in the
linear scale. Only genes with a gene symbol annotation were considered. Differential genes counts are shown for each of the three different
treatments, either 10 ng/ml NGF or 20 ng/ml of proNGF-WT or -KR, at the two selected time points (1 h and 4 h). (A) Counts of differential genes in
the different regions of the Venn diagram referring to the three treatments; all the seven gene sets are disjoint, at each time point, with no element
in common. (B) Counts of differential genes in four highlighted gene sets: color of bars correspond to the regions in the Venn Diagrams on the
right.
doi:10.1371/journal.pone.0020839.g004
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for differentially expressed genes, in the three disjoint sets NGF, proNGF-WT, proNGF-KR (see Figure 4B), at 1 hour (A) and 4 hour time (B). Genes
were selected by one-way ANOVA (p,0.05), assuming not equal variance. The fold change values (fc) for down-regulated probes, by definition ,1.0,
were converted into values .1.0 as 1/fc. The distributions of fold change, NGF vs proNGF-WT and NGF vs proNGF-KR, were clearly distinct and were
compared using the 2-side Kolmogorov-Smirnov test for two samples. The fold change values at 50% of the distribution at 1 h for (NGF, proNGF-WT,
proNGF-KR) are respectively (1.25, 1.23, 1.23) while at 4 h they are (1.34, 1.22, 1.23). The foldchange values at 90% of the distribution at 1 h for (NGF,
proNGF-WT, proNGF-KR) are respectively (1.40, 1.32, 1.30) while at 4 h they are (1.74, 1.29, 1.32).
doi:10.1371/journal.pone.0020839.g005
Table 1. Main functional categories of differentially expressed genes belonging to the four analyzed set regions shown in the
Venn diagram of Figure 4B.
NGF 1 h NGF 4 h proNGF-WT 1 h proNGF-WT 4 h proNGF-KR 1 h proNGF-KR 4 h proNGF 1 h proNGF 4 h
cell cycle cell cycle cell cycle cell cycle cell cycle cell cycle cell cycle
intracellular
trafficking /
synaptic activity
intracellular
trafficking /
synaptic activity
intracellular
trafficking /
synaptic activity
intracellular
trafficking /
synaptic activity
intracellular
trafficking /
synaptic activity
intracellular
trafficking /
synaptic activity
intracellular
trafficking /
synaptic activity
DNA repair DNA repair DNA repair DNA repair DNA repair DNA repair
ionic trasport ionic trasport ion transport ion transport ion transport
stress response stress response stress response
kinases and
phosphatases
kinases and
phosphatases
carbohydrate
metabolism
carbohydrate
metabolism
transcription factor transcription factor transcription factor
development development
lipid metabolism lipid metabolism
DNA replication
RNA processing
Embryonic
development
structural proteins
cell adhesion
cell migration
chaperones
receptors
Main functional categories of differentially expressed genes belonging to the four analyzed set regions shown in the Venn diagram of Figure 4B: NGF\{proNGF-WT U
proNGF-KR} (light blue in Figure 4B, NGF in Table 1), proNGF-WT\{NGF U proNGF-KR} (orange in Figure 4B, proNGF-WT in Table 1), proNGF-KR\{NGF U proNGF-WT} (blue
in Figure 4B, proNGF-KR in Table 1), {proNGF-KR > proNGF-WT}\NGF (brown in Figure 4B, proNGF in Table 1).
doi:10.1371/journal.pone.0020839.t001
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proteins that repair DNA breaks by recombination.
As for the ‘‘pure proNGF’’ set, many genes involved in
carbohydrate- as well as in lipid-metabolism were found to be
significantly down-regulated. Interestingly, it has been recently
shown [51] that proNGF is modified by non-enzymatic glycation
and lipidation in AD (Table 1), although we cannot directly
compare these modifications with the regulation by proNGF of
carbohydrate and lipid post-translationally modifying enzymes,
highlighted in PC12 cells.
We then analyzed the genes specific for proNGF-WT and
proNGF-KR, represented in the Venn diagrams by the orange
and blue colours, respectively. The two proNGF-WT and -KR
specific datasets contain different number of genes and different
gene classes, suggesting that these two proteins behave somewhat
differently. Since the two proNGF –WT and –KR proteins have
been widely used interchangeably [8,52] and functional differ-
ences among them have not been reported, we ascribe the
transcriptional differences highlighted in this analysis to their
differential processing during the incubation with PC12 cells, and
hence to a distinct contribution by mature NGF in the two
conditions.
The results underscore the importance of the relative amount of
NGF versus proNGF in the biological outcome. It appears therefore
critical, when taking into account the signalling fingerprinting of
proNGF, to consider both the amount of mature and precursor
protein, particularly for in vivo situations.
One gene family significantly modulated in the two treatments
at 4 h is linked to synaptic functions and activity (genes involved in
vescicular transport, ion channels, protein trafficking), although in
the case of proNGF-WT, these genes are all down-regulated, while
in the case of proNGF-KR they do not have a homogeneous
trend, being partly up- and partly down-regulated.
Finally, the expression trend of specific genes, known to be
linked to NGF and proNGF activity, were sought and analyzed in
the different datasets.
We could identify furin to be down-regulated in ‘‘pure
proNGF’’ set, suggesting a feedback regulation loop possibly
fine-tuning and reinforcing proNGF activity, by reducing its
metabolism. Significantly, in the proNGF-WT at 1 h, the TrkA
receptor gene is down regulated, further suggesting a feedback
effect of proNGF-WT, leading to a reduced efficacy of signal
transduction mediated by TrkA receptor.
Despite the evidence of the cross-talk between the p75
NTR and
sortilin in the cell death induced by proNGF, we could not find a
modulation in these receptors’ genes in the proNGF treatments.
However, this agrees well with the finding that the protein levels of
p75
NTR and sortilin are unaffected in neurodegeneration states
[25,26].
Figure 6. Summary of regulated cell-cycle genes. Summary counts of up-regulated and down-regulated cell cycle genes with a clear
involvement in apoptotic and proliferative processes, for the NGF treatment and for the intersection between proNGF-WT and –KR at 1 h treatments.
In the tables on the right, the names of the counted genes with the corresponding up-regulated (+) or down-regulated (2) trend.
doi:10.1371/journal.pone.0020839.g006
Table 2. Summary counts of the main up- and down-
regulated transcription factors genes.
NGF\{proNGF-WT U
proNGF-KR}
(proNGF-WT >
proNGF-KR)\NGF
Up q Down Q Up q Down Q
1h 30 0 13 0
4h 114 13 0 0
Summary counts of up- and down-regulated transcription factors genes with a
fold change larger than 1.2 or lower than 1/1.2 in the linear scale, for the NGF
treatment and for the intersection between proNGF-WT and -KR. The headers
correspond to the regions in the Venn diagram of Figure 4B and the gene sets, at
each time point, are disjoint. The transcription factors belong to the sets in
Figure 4B {NGF\{proNGF-WT U proNGF-KR}} (left side – corresponding to the blue
inFigure 4B)and{{proNGF-KR>proNGF-WT}\NGF} (rightside–correspondingto
the brown in Figure 4B).
doi:10.1371/journal.pone.0020839.t002
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rat CNS neurons, the phosphatase and tensin homolog deleted on
chromosome 10 gene pTen [53], is not differentially expressed in
our system.
Discussion
The cellular response to NGF has been extensively studied in
the PC12 cell line, both in terms of the cellular phenotype, of
signalling, and, more recently, of the transcriptional profiles
[45,54]. In light of recent studies pointing to an independent and
distinct biological role for the NGF precursor protein proNGF,
particularly relevant in neurodegeneration, we investigated the
properties of proNGF signalling by gene expression microarray,
since very little is known in this respect, for proNGF.
The aim of the experiment was to exploit transcriptional
regulation as a ‘‘signalling signature’’ to address the question
whether NGF and proNGF show only quantitative or also
qualitative differences in their respective transcriptional activation
programs.
The present is therefore the first study, aimed at an overall
comparison of the genes induced in PC12 cells upon treatment
with mature NGF or its precursor.
In order to isolate as much as possible the effects of a ‘‘pure’’
proNGF system, we treated the cells either with proNGF-WT or
with the furin resistant mutant proNGF-KR. A limited partial
processing of the proteins by other extracellular protease still
occurs, as also demonstrated in the literature [8,9]. Therefore we
concentrated on the early response in the system (1 and 4 hours),
when the processing of the proNGF proteins is lower. Using this
approach, we were able to conclude that NGF and proNGF
activate distinct transcriptional programs and to identify a specific
proNGF transcription signature, distinct from NGF.
Our results clearly show that NGF and proNGF signalling
mediate distinct mRNA expression patterns, not only in terms of
total number of modulated genes (a higher number for NGF than
for the proNGFs – See Figure 4), but also in terms of gene families
(see Table 2).
The functional analysis of NGF-induced transcriptional data
allowed us, at first, to confirm previously published studies on
NGF-induced microarray profiles in PC12 cells. Indeed, we
observed that transcription factors and gene expression related
processes are heavily induced by NGF.
We then analyzed the system by taking into account certain
subsets of differentially expressed genes. In particular, we focussed
on the intersection set genes induced both by proNGF-WT and
proNGF-KR, that we called the ‘‘pure proNGF’’ subset. We
compared this identified group of genes, with those activated by
NGF and with those activated by either proNGF-WT or proNGF-
KR selectively.
In general, we observed in the proNGF transcriptional activity
the absence of certain gene families heavily activated by NGF. We
could identify certain gene families mainly activated by the ‘‘pure
proNGF’’. Most significantly, proNGF was shown to induce genes
connected to carbohydrate and lipid metabolism.
Although in a different context, it has been recently shown [51]
that proNGF is modified by non-enzymatic glycation and
lipidation in AD, therefore this kind of modifications could be
interpreted as a specific signature of the protein. It is remarkable
that the modulation of the lipid metabolism, and of genes of the
cholesterol biosynthesis among these, is a specific signature for the
proNGF treatment. Indeed, it has been shown that cholesterol
biosynthesis is connected on one side to the p75
NTR-mediated
signalling and apoptosis [55–57], and on the other side to the
progression of AD [58,59]. Given the proposed role of proNGF in
p75
NTR-mediated apoptosis [8] and the unbalance of the
proNGF/NGF ratio in AD [18,27,60], further analysis will be
required to evaluate the importance of this pathway in the specific
biological outcome of proNGF in cellular systems and in vivo.
A further discriminating category between NGF and proNGF is
the cell cycle family, encompassing mainly pro-proliferative genes
in the case of NGF and pro-apoptotic genes in the case of proNGF
at 1 h of treatment. Other mRNA families distinctly regulated
involve DNA replication and chromatin remodelling, which are
differentially expressed after exposure to either NGF or proNGF,
but usually in opposite directions, which leads to suggest a
differential effect of the two neurotrophin forms even on common
pathways.
Particularly notable is the difference in the regulation of
mRNAs coding for transcription factors. In particular, proNGF
was found to modulate a smaller number of transcription factor
genes compared to NGF and the treatment of PC12 cells with
NGF or proNGF appears to have a completely different effect on
the cellular response. While in the case of NGF, the modulated
transcription factors are connected with a regenerative/differen-
tiative trend, those modulated by proNGF are more connected
with a less proliferative cell.
From our analysis, we suggest that the relative ratio of NGF
versus proNGF is critical for the downstream transcriptional
signalling. In fact, we observe that there is a significant number
of genes selectively modulated by proNGF-WT or proNGF-KR,
and that for each of the two subsystems, the genes overlapping
with those of NGF in the two cases are also different. This
observation well fit with our hypothesis that the kinetic of
interconversion of proNGF-WT and –KR into NGF is likely to
be different, due to the removal of one dibasic aminoacid site in
the proNGF-KR. The consequence of a different proteolytic
kinetic is that the PC12 cells system is exposed to a progressively
different NGF/proNGF protein ratio, in the time windows
considered. This could account for the difference between the
two datasets. The relative ratio of NGF/proNGF is surely
important for the biological response of the cellular treatment
with the neurotrophins.
The regulation of the NGF/proNGF ratio in vivo might
therefore have profound consequences, further underscoring the
Table 3. Functional analysis of genes induced by the
transcription factors modulated by NGF and proNGF after 1 h
of treatment.
Functional cluster
Geometric mean of cluster
terms p-values
NGF regulation of gene expression 2.02E-06
regulation of transcription 1.05E-05
regulation of angiogenesis 1.58E-03
proNGF mitochondrial membrane 3.09E-04
RNA transport 1.90E-02
regulation of metabolic process 2.61E-02
Main DAVID functional clusters of gene lists obtained by computing the
standard correlation of transcription factors after 1 h, listed in Table 2, with the
expression values of the whole set of data and selecting only the genes with
absolute correlation value .0.90. The transcription factors belong to the sets in
Figure 4B {NGF\{proNGF-WT U proNGF-KR}} (light blue in Figure 4B, NGF in
Table 3) and {{proNGF-KR > proNGF-WT}\NGF} (brown in Figure 4B, proNGF in
Table 3).
doi:10.1371/journal.pone.0020839.t003
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vivo situations.
These results fit well with data in the literature [30], showing
how the biological outcome of proNGF is finely tuned by the
amount of protein, as well as by the relative ratios of the involved
receptors. Our results help also explaining why proNGF is able to
induce distinct biological effects in different cellular systems and
different biological conditions [8,17,29,61]. A strong unbalance
towards ‘‘pure’’ NGF is unlikely to be found in vivo, where the co-
existence of the mature and precursor neurotrophins has been
widely observed. Moreover, in pathological conditions, such as
brain injury or Alzheimer’s disease, the equilibrium between
synthesis and cleavage of proNGF was demonstrated to be in
favour of the precursor form [18,52]. Therefore, the life/death
effects induced by NGF and proNGF appear to be strictly related
to their relative ratio in vivo. Indeed, being the two neurotrophin
forms able to activate different transcriptional programs, we
suggest that the biological effects exerted in vivo are a result of a
complex balance between their specific signalling and transcrip-
tional programs.
In conclusion, we report herein the first characterization of the
differential transcriptional signature of proNGF versus NGF, in
PC12 cells. From our data, we confirm that the mature and the
precursor proteins are biologically different, and show a different
transcriptional signature. These results open the path for
subsequent more detailed studies of the distinct transcriptional
pathways activated by NGF and proNGF, in order to better
characterize their different biological activity in vivo.
Materials and Methods
Cloning and expression of mouse short proNGF (proNGF)
The cDNA sequence of the short form of proNGF, corresponds
to bp 348 to 1010 (NCBI entry M35075); from aminoacid 2103 to
aminoacid +118 (Figure 1A). proNGF was cloned and expressed in
E. coli according to the protocols described in [14].
The mutant protein proNGF-KR carries a change from
aminoacids KR to AA at position 22, 21 (Figure 1A), which
destroys the cleavage site by furin protease [52]. The mutant was
obtained by site-directed mutagenesis by Stratagene Kit. The
correct cDNAs were subcloned into the pET11a vector (Novagen).
The protein was expressed following the same protocol described
for wild-type proNGF [14]. NGF was obtained from proNGF, by
‘‘in vitro’’ proteolytic cleavage with trypsin [14].
Receptors characterization in the PC12 SB subclone
Rat pheochromocytoma PC12 cells [31] (PC12 SB subclone)
were maintained with RPMI 1640 Medium (Invitrogen) and
grown as monolayer cultures on Falcon dishes, supplemented
with 10% Horse Serum (Invitrogen) and 5% Foetal Calf
Serum (Invitrogen), in a humidified atmosphere at 37uC and 5%
CO2.
Cell dishes were washed with PBS, incubated on ice with lysis
buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100,
0.1% SDS, 10 mM EDTA), then scraped and centrifuged. Protein
concentration of the supernatant was evaluated by Bradford Assay
(Sigma). 60 mg of the total protein lysate was loaded onto a
Criterion
TM XT Bis-Tris Gel, 4–12% (BioRad) to perform
Western Blotting. The membrane was cut and challenged with
anti TrkA (Chemicon), anti Sortilin (R&D System) and anti
p75NTR (Alomone Labs), according by the manufacturer’s
protocol, and then with the proper secondary antibodies, HRP
conjugated, at 1:7000 (all by Jackson Lab).
PC12 cells treatment and differentiation bioassay
Rat pheochromocytoma PC12 cells [31] (PC12 SB subclone,
kindly provided by Maurizia Caruso, Consiglio Nazionale delle
Ricerche, INMM, Rome, Italy) were maintained with RPMI 1640
Medium (Invitrogen) and grown as monolayer cultures on Falcon
dishes, supplemented with 10% Horse Serum (Invitrogen) and 5%
Foetal Calf Serum (Invitrogen), in a humidified atmosphere at
37uC and 5% CO2. For differentiation, PC12 cells were plated at a
concentration of 10
6/dish (100 mm plates, BD Falcon) and kept in
culture for 12 hours. Cells were treated with 10 ng/ml NGF,
20 ng/ml of wild type (WT) proNGF or 20 ng/ml of furin-
cleavage resistant proNGF-KR.
After 72 hours, the medium was changed and free medium+-
proteins was supplied. Following different incubation times, light
microscope pictures were taken of the living differentiating cells
and neurite extension was evaluated.
For microarray mRNA expression analysis, half volume of
medium was replaced with fresh medium and the naı ¨ve PC12 cells
were treated for 1 h or 4 h with 20 ng/mL of proNGF or
proNGF-KR or 10 ng/mL NGF. A negative control with no
neurotrophin addition was performed.
In order to evaluate cells morphology in the same experimental
conditions used for RNA extraction, a triple immunofluorescence
was performed on PC12 cells exposed to analogous treatments
(20 ng/mL of proNGF or proNGF-KR or 10 ng/mL NGF). After
1 h or 4 h cells were fixed [62] and stained with anti-beta III
tubulin antibody (Covance, 1:250 dilution), Alexa 594 phalloidin
(Invitrogen, 1:40 dilution), to visualize filamentous actin, and
DAPI for nuclear staining. Coverslips were mounted using
Vectashield (Vector) mounting medium. Stained cells were
analyzed by confocal laser scanning microscopy on Leika
microscope.
The apoptosis in PC12 cells was evaluated with the TUNEL
method (Terminal deoxynucleotidyl transferase dUTP nick end
labeling) using the ApopTag detection Kit (Merck Millipore),
according to manufacturer’s instructions.
Determination of proNGF stability
The processing of the proNGF proteins in the PC12 cells
culture was evaluated by a spiking experiment. The amount of
neurotrophins used in the PC12 cells treatment for the microarray
experiments is too low to be detected in a direct Western Blot
analysis, and does not allow to quantify the precise percentage of
NGF cleaved from the two forms of the precursor during the
incubation. To this aim, a sufficient amount of the recombinant
proteins was spiked into the conditioned medium (CM) of treated
PC12 cells, in the same conditions of temperature and time used
for the microarray experiment. In details, 1 mg of recombinant
proNGF-WT, proNGF-KR or NGF was spiked into 50 mLo f1h
the conditioned medium (CM) or 4 h CM of treated PC12 cells, in
the same conditions of temperature and time used for the
microarray experiment.
The spiked medium was incubated at 37uC for 1 h or 4 h and
then 20 mL/sample were run on SDS-PAGE for Western blotting
analysis with an anti-NGF antibody (Jackson Lab).
PC12 cells were washed, fresh medium was added and kept for
1 h or 4 h (1 h CM or 4 h CM). Primary antibody: anti-NGF
M13 (Santa Cruz), at a 1:200 concentration, 16 hours at 4uC.
Secondary antibody: Goat Anti-Rabbit, HRP conjugated (Jackson
Lab), 1:7000, 1 hour at room temperature.
The ratio between the intact proNGF and the NGF produced
by processing from input proNGF (degradation ratio) was
determined by a densitometric analysis of the bands in each lane,
performed with the Kodak digital imager.
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RNA was isolated from four different PC12 cell cultures, PC12
cells treated with NGF, wild type proNGF (proNGF-WT) or furin
resistant proNGF (proNGF-KR) or untreated cells. Neurotrophin
treated cell cultures were sampled at two different incubation times
(1 and 4 hours). Two biological replicates were used for each time
point and treatment.
PC12 cell cultures were scraped and lysed with Trizol
(Invitrogen) and DNAse treated by Qiagen columns. RNA
quantity was determined on a NanoDrop UV-VIS. Only samples
with an absorbance ratio of 1.8,OD260/OD280,2.0 were
processed further. Each sample was then quality checked for
integrity using the Agilent BioAnalyzer 2100 (Agilent G2938C,
RNA 6000 nano kit): samples with a RNA Integrity Number
(RIN) index lower than 8.0 were discarded. 500 ng of RNA were
used for each reaction. cRNA was synthesised from double-
stranded cDNA during in vitro transcription with T7 RNA
polymerase, labelled using Cyanine 3-CTP or Cyanine 5-CTP
(Perkin Elmer) and purified (Qiagen’s RNeasy mini spin columns).
Hybridization of oligonucleotide Rat microarrays
The gene expression profiling was performed using the two-
color Agilent protocol (http://www.chem.agilent.com/en-US/
Products/Instruments/dnamicroarrays/Pages/default.aspx).
cRNA samples from the treated cells were labelled by Cyanine-
5, while the control samples (from untreated cells) were labelled by
Cyanine-3. Labelled cRNA samples (825 ng each sample) were
hybridized to Agilent 4644 k whole Rat genome oligonucleotide
microarrays (G4131F) at 65uC for 17 hours using Agilent’s Gene
Expression Hybridization Kit. The hybridized microarrays were
disassembled at room temperature in Agilent Gene Expression
Wash Buffer 1. After the disassembly, the microarrays were
washed in Gene expression Buffer 1 for one minute at room
temperature, followed by washing with Gene Expression Wash
Buffer 2 for one minute at 37uC. The microarrays were then
treated with acetonitrile for one minute at room temperature.
Scanning, feature extraction and analysis
Post-hybridization image acquisition was accomplished using
the Agilent scanner G2564B, equipped with two lasers (532 nm
and 635 nm) and a 48 slide auto-sampler carousel. The ‘‘extended
range’’ scanning protocol was used, where the output of two
following scannings at 10% and 100% of laser power are
numerically combined. Data extraction from the images was
accomplished by Agilent Feature Extraction 9.1 software, using
the standard Agilent two-color gene expression extraction protocol
(GE2-v4_91).
Raw data filtering was performed in Microsoft Excel using any
of the following criteria to discard spots: spots with more than 5%
of saturated pixel in any of the two channels, spots flagged as ‘‘not
found’’ by the Feature Extraction software in any of the two
channels, spots with a Signal/Noise ratio smaller than 3 in any of
the two channels, where Signal=(median of the spot2median
spot background level) and Noise is the IQR (interQuantileRange)
of the median spot background. Data analysis was performed on
filtered data using Agilent GeneSpring GX 7.3 and Microsoft
Excel. Each array was normalized by the Lowess algorithm within
GeneSpring, using 20% of data as smoothing window.
Differentially modulated gene families were identified bioinfor-
matically from the Panther (Protein ANalysis THrough Evolu-
tionary Relationships) database of Biological Processes (http://
www.pantherdb.org/tools/genexAnalysis.jsp), using the Wilcoxon
Rank-Sum Test (p-value,0.05) on two-column tables including
the list of differentially expressed genes and the related fold change
values. The PANTHER Classification System is a freely available
web-based resource that classifies genes by their functions, using
both published experimental evidence and evolutionary relation-
ships for predictions. Genes and proteins are classified by expert
curators according to: Gene families and subfamilies, Gene
Ontology classes (molecular function, biological process, cellular
component), PANTHER Protein Classes, Pathways. The gene lists
used for this Panther analysis were obtained from the whole set of
filtered and normalized data, with the following two additional
criteria: genes without an official Gene Symbol were excluded
from the analysis; in the case of more than one mRNA probe
referring to the same gene, the most significant value (based on the
largest absolute log2 value of fold change) was chosen.
As a result, 4 lists of statistically significant Panther categories
were obtained, one for each treatment (NGF, proNGF-WT,
proNGF-KR) and one for the intersection between proNGF-WT
and proNGF-KR treatments, including in each list only disjoint
category terms. Each of these lists was analyzed at two time points
(1 and 4 hours).
Four disjoint sets of differentially expressed genes, showing
directional fold change larger than 1.2 or lower than 1/1.2 in the
linear scale, were compiled: one for each treatment (NGF,
proNGF-WT, proNGF-KR) and one for the intersection between
proNGF-WT and proNGF-KR treatments, at the two time points
(1 and 4 h) (see the Venn diagram in Figure 4). Only the genes
with a match in the corresponding sets of statistically significant
Panther terms, based on the gene annotation in the Panther
database, were eventually selected.
Transcription factors were identified by the DAVID tool [63]
from the sets of differentially expressed genes; DAVID was also
used for annotation of individual genes.
Supporting Information
Figure S1 PC12 cells treated with the recombinant
neurotrophins – 72 h after treatment. Panel A – 50 ng/mL
of NGF. Panel B – 100 ng/mL of proNGF-WT. Panel C – 100 ng/
mL of proNGF-KR. Panel D – Control without addition of
neurotrophins.
(TIF)
Figure S2 Receptors characterization in the PC12 SB
subclone. PC12 cells lysate was subjected to Western blotting.
The antibodies for the three receptors (TrkA, p75NTR and
sortilin) were used.
(TIF)
Table S1 List of differentially expressed genes at the
two selected time points, 1 and 4 hours. Selected geneshave
an absolute directional fold change larger than 1.2 and an official
gene symbol annotation. The colours on the top correspond to
the highlighted subsets in the Venn diagram of Figure 4B:
NGF\{proNGF-WT U proNGF-KR} in light blue, proNGF-
WT\{NGF U proNGF-KR} in orange, proNGF-KR\{NGF U
proNGF-WT} in blue, {proNGF-KR > proNGF-WT}\NGF in
brown.
(XLS)
Table S2 Differentially modulated processes for each of
the three different treatments, at 1 and 4 hours. The
items were selected from the Panther Database of Biological
Processes (http://www.pantherdb.org/tools/genexAnalysis.jsp) us-
ing the Wilcoxon Rank-Sum Test (p-value,0.05) on two-columns
tables including the list of differentially expressed genes and the
related fold change values. The processes specific to each treatment
and time point are highlighted in bold while the processes common
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1 h and 4 h, are highlighted in italic bold.
(PDF)
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